<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03128853</url>
  </required_header>
  <id_info>
    <org_study_id>TP-18216</org_study_id>
    <nct_id>NCT03128853</nct_id>
  </id_info>
  <brief_title>Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility</brief_title>
  <official_title>Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masimo Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Masimo Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single-arm study to investigate the repeatability and reproducibility of SpHb measurements
      from the Rad-67 and DCI Mini sensor.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to evaluate the repeatability and reproducibility of Masimo's pulse
      CO-Oximeter and sensor to determine the device and sensor's precision in SpHb measurements.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 31, 2016</start_date>
  <completion_date type="Actual">November 15, 2016</completion_date>
  <primary_completion_date type="Actual">November 15, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Repeatability and reproducibility of CO-oximeter and sensor</measure>
    <time_frame>120 minutes</time_frame>
    <description>The Repeatability and Reproducibility of the sensor will be assessed by varying the testing conditions (operator/device, finger, subject, and repetition) to determine the device and sensor's precision in SpHb measurements.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Anemia</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Test subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each subject receives the Rad-67 and DCI Mini sensor that will measure hemoglobin repeatedly in order to compare those measurements against a blood sample reference.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Rad-67 and DCI Mini Sensor</intervention_name>
    <arm_group_label>Test subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age one month and older

          -  Weight greater than or equal to 3 kg

          -  The subject or the subject's legally authorized representative has given written
             informed consent/assent to participate in the study

        Exclusion Criteria:

          -  Decision-impaired adult and pediatric patients who are unable to give informed
             consent/assent

          -  Decision-impaired adult on behalf of a pediatric patient who is unable to assent

          -  Subjects with skin abnormalities at the planned application sites that may interfere
             with sensor application, per directions-for-use (DFU) or trans-illumination of the
             site, such as burns, scar tissue, nail polish, acrylic nails, infections,
             abnormalities, etc.

          -  Subjects deemed not suitable for the study at the discretion of the investigator

          -  Subjects unlikely to be able to refrain from excessive motion during data collection.
             Excessive motion includes postural changes, making hand gestures, involuntary muscular
             movements, etc.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Masimo Clinical Laboratory</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92618</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Site 1</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 14, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2017</study_first_posted>
  <disposition_first_submitted>April 1, 2019</disposition_first_submitted>
  <disposition_first_submitted_qc>April 1, 2019</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">April 8, 2019</disposition_first_posted>
  <last_update_submitted>April 22, 2020</last_update_submitted>
  <last_update_submitted_qc>April 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

